FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma
2025 · Cancer Cell · 25 citations
https://doi.org/10.1016/j.ccell.2025.02.001
K
Kuniaki Sato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
179
Papers
1.3K
Citations
20
h-index
34
i10-index
Kuniaki Sato is an academic researcher from University of San Diego. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related molecular mechanisms research & Ferroptosis and cancer prognosis. The author has an h-index of 20, co-authored 153 publications.
ORCID: 0000-0001-6014-1911Papers by this author
worksTargeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma
2025 · Cancer Letters · 19 citations
https://doi.org/10.1016/j.canlet.2025.217467
YAP-driven malignant reprogramming of oral epithelial stem cells at single cell resolution
2025 · Nature Communications · 14 citations
https://doi.org/10.1038/s41467-024-55660-6
N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study
2020 · International Journal of Molecular Sciences · 11 citations
https://doi.org/10.3390/ijms21020511
YAP-Driven Malignant Reprogramming of Epithelial Stem Cells at Single Cell Resolution
2023 · Research Square · 4 citations
https://doi.org/10.21203/rs.3.rs-3426301/v1
Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinoma
2022 · Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo) · 0 citations
https://doi.org/10.3950/jibiinkotokeibu.125.5_916
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat